YU192186A - Process for obtaining thiazol/4,5-c/quinoline - Google Patents

Process for obtaining thiazol/4,5-c/quinoline

Info

Publication number
YU192186A
YU192186A YU01921/86A YU192186A YU192186A YU 192186 A YU192186 A YU 192186A YU 01921/86 A YU01921/86 A YU 01921/86A YU 192186 A YU192186 A YU 192186A YU 192186 A YU192186 A YU 192186A
Authority
YU
Yugoslavia
Prior art keywords
thiazol
quinoline
obtaining
obtaining thiazol
Prior art date
Application number
YU01921/86A
Other languages
English (en)
Inventor
J Marij
E Berneyi
K Budai
B Knol
Z Furts
J Timbr
G Zsila
I Niklya
L Petocz
A Mandi
Original Assignee
Egis Gxogxszergyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gxogxszergyar filed Critical Egis Gxogxszergyar
Publication of YU192186A publication Critical patent/YU192186A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
YU01921/86A 1985-11-12 1986-11-12 Process for obtaining thiazol/4,5-c/quinoline YU192186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU854304A HU197019B (en) 1985-11-12 1985-11-12 Process for producing thiqzolo (4,5-c) quinoline derivatives and pharmaceuticals comprising same

Publications (1)

Publication Number Publication Date
YU192186A true YU192186A (en) 1988-10-31

Family

ID=10967593

Family Applications (1)

Application Number Title Priority Date Filing Date
YU01921/86A YU192186A (en) 1985-11-12 1986-11-12 Process for obtaining thiazol/4,5-c/quinoline

Country Status (24)

Country Link
US (1) US4904669A (es)
JP (1) JPS62161792A (es)
CN (1) CN86107754A (es)
AU (1) AU592384B2 (es)
BE (1) BE905719A (es)
BG (1) BG46156A3 (es)
CH (1) CH670829A5 (es)
DD (1) DD254202A5 (es)
DE (1) DE3638563A1 (es)
DK (1) DK539786A (es)
ES (1) ES2002543A6 (es)
FI (1) FI864611A (es)
FR (1) FR2603588A1 (es)
GB (1) GB2184117B (es)
HU (1) HU197019B (es)
IL (1) IL80611A0 (es)
IT (1) IT1213379B (es)
NL (1) NL8602878A (es)
NO (1) NO864518L (es)
PL (1) PL148186B1 (es)
SE (1) SE8604839L (es)
SU (1) SU1544190A3 (es)
YU (1) YU192186A (es)
ZA (1) ZA868583B (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU199423B (en) * 1987-04-24 1990-02-28 Egyt Gyogyszervegyeszeti Gyar Process for producing 3-amino-4-/ethylthio/-quinoline and pharmaceutical compositions comprising such compounds
US6110929A (en) * 1998-07-28 2000-08-29 3M Innovative Properties Company Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
US6677347B2 (en) * 2000-12-08 2004-01-13 3M Innovative Properties Company Sulfonamido ether substituted imidazoquinolines
US20040214851A1 (en) * 2003-04-28 2004-10-28 3M Innovative Properties Company Compositions and methods for induction of opioid receptors
BRPI0412902A (pt) * 2003-08-12 2006-09-26 3M Innovative Properties Co compostos contendo imidazo substituìdo por oxima
CA2536136C (en) * 2003-08-27 2012-10-30 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
AU2004270201A1 (en) * 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for CD5+ B cell lymphoma
CA2540541C (en) * 2003-10-03 2012-03-27 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US20090075980A1 (en) * 2003-10-03 2009-03-19 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and Analogs Thereof
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
WO2005048933A2 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
US8598192B2 (en) * 2003-11-14 2013-12-03 3M Innovative Properties Company Hydroxylamine substituted imidazoquinolines
AU2004293078B2 (en) * 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (en) * 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl and arylalkynyl substituted imidazoquinolines
WO2005066169A2 (en) * 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
CA2559863A1 (en) * 2004-03-24 2005-10-13 3M Innovative Properties Company Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
WO2005123080A2 (en) * 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) * 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009832A1 (en) * 2004-06-18 2006-01-26 3M Innovative Properties Company Substituted imidazo ring systems and methods
US7915281B2 (en) * 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
US8026366B2 (en) * 2004-06-18 2011-09-27 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
WO2006026760A2 (en) * 2004-09-02 2006-03-09 3M Innovative Properties Company 1-amino imidazo-containing compounds and methods
WO2006063072A2 (en) * 2004-12-08 2006-06-15 3M Innovative Properties Company Immunomodulatory compositions, combinations and methods
US7943609B2 (en) * 2004-12-30 2011-05-17 3M Innovative Proprerties Company Chiral fused [1,2]imidazo[4,5-C] ring compounds
ES2392648T3 (es) 2004-12-30 2012-12-12 3M Innovative Properties Company Compuestos quirales sustituidos que contienen un núcleo 1,2-imidazo-4,5-c condensado
US9248127B2 (en) * 2005-02-04 2016-02-02 3M Innovative Properties Company Aqueous gel formulations containing immune response modifiers
WO2007120121A2 (en) * 2005-02-09 2007-10-25 Coley Pharmaceutical Group, Inc. Oxime and hydroxylamine substituted thiazolo[4,5-c] ring compounds and methods
EP1846405A2 (en) 2005-02-11 2007-10-24 3M Innovative Properties Company Oxime and hydroxylamine substituted imidazo 4,5-c ring compounds and methods
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
CA2602590A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
WO2008008432A2 (en) * 2006-07-12 2008-01-17 Coley Pharmaceutical Group, Inc. Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
KR20210082473A (ko) 2018-10-23 2021-07-05 바스프 에스이 트리시클릭 살충 화합물
WO2021209265A1 (en) 2020-04-14 2021-10-21 Basf Se Tricyclic pesticidal compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2024207A (en) * 1978-05-26 1980-01-09 Lepetit Spa New tricyclic ortho-fused heterocyclic compounds
HU196308B (en) * 1985-11-12 1988-11-28 Egyt Gyogyszervegyeszeti Gyar Process for producing pharmaceutical compositions containing 2-methyl-thiazolo/4,5-c/quinoline as active component

Also Published As

Publication number Publication date
ES2002543A6 (es) 1988-08-16
US4904669A (en) 1990-02-27
CN86107754A (zh) 1987-08-05
SE8604839L (sv) 1987-05-13
JPS62161792A (ja) 1987-07-17
HUT44260A (en) 1988-02-29
FI864611A0 (fi) 1986-11-12
IT1213379B (it) 1989-12-20
NO864518L (no) 1987-05-13
SE8604839D0 (sv) 1986-11-12
FR2603588A1 (fr) 1988-03-11
NL8602878A (nl) 1987-06-01
GB8627043D0 (en) 1986-12-10
BE905719A (fr) 1987-05-07
IT8622312A0 (it) 1986-11-12
DK539786D0 (da) 1986-11-12
DD254202A5 (de) 1988-02-17
ZA868583B (en) 1987-08-26
SU1544190A3 (ru) 1990-02-15
NO864518D0 (no) 1986-11-12
DE3638563A1 (de) 1987-06-25
AU6508986A (en) 1987-05-14
FI864611A (fi) 1987-05-13
BG46156A3 (en) 1989-10-16
PL148186B1 (en) 1989-09-30
GB2184117B (en) 1989-10-11
HU197019B (en) 1989-02-28
DK539786A (da) 1987-05-13
IL80611A0 (en) 1987-02-27
GB2184117A (en) 1987-06-17
PL262346A1 (en) 1988-03-03
AU592384B2 (en) 1990-01-11
CH670829A5 (es) 1989-07-14

Similar Documents

Publication Publication Date Title
YU192186A (en) Process for obtaining thiazol/4,5-c/quinoline
YU116787A (en) Process for obtaining imidazochynolinic derivatives
YU154986A (en) Process for obtaining bis-phosphitic compounds
YU27788A (en) Process for obtaining quinoline derivatives
YU183586A (en) Process for obtaining chynoline derivatives
YU44294B (en) Process for obtaining new antihypertenzic compounds
YU128086A (en) Process for obtaining flavanolignane complex with phospholipides
YU62385A (en) Process for obtaining 9a-aza-9a-homoeritromicyn derivatives
YU99386A (en) Process for obtaining new thienopyridones
YU44603B (en) Process for obtaining hynolone
YU207285A (en) Process for obtaining imidazolinealkylguanidinic derivatives
YU137186A (en) Process for obtaining cephalosporinic salts
PT80336A (en) Process for the iminothiazolidine derivatives
HUT41008A (en) Process for producing quinoline derivatives
YU167087A (en) Process for obtaining 4,4-dialkyl-2-azetidinone
PL261846A1 (en) Method for manufacturing netilmycyn
YU100886A (en) Process for obtaining 2-bromine-alpha-ergocriptine
PT79987A (en) Process for preparing 2-arylimidazo<4,5-c>pyridines
YU6185A (en) Process for obtaining phenoxi-benzaldeniodic derivatives
YU107986A (en) Process for obtaining 2-halonicergilinic derivatives
YU108586A (en) Process for obtaining new betalactamic derivatives
HUT44563A (en) Process for preparing pyridiyl-substituted imidazo/2,1-b/ thiazoles
YU53085A (en) Process for obtaining eburhanic derivatives
RO91191B1 (ro) Procedeu de obtinere a xanthidrolului
YU155885A (en) Process for obtaining benzatine phenoximethylpenicilin